U S Physical Therapy (NYSE: USPH) insider transactions

In the twelve months to 10 November 2026, executives and directors of U S Physical Therapy reported 5 open-market sales of 6,213 shares ($498,590) and 5 open-market purchases of 4,786 shares ($325,251), by 4 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in U S Physical Therapy shares reported on Form 4
Date	Insider	Role	Transaction	Shares	Price	Held after	Filing
1 October 2026	Davis Myra	Director	Grant or award	+1,210	—	1,210	Form 4
14 September 2026	Etta Nchacha	EVP & Chief Financial Officer	Grant or award	+6,831	—	6,831	Form 4
11 September 2026	Minan Peter Francis	Director	Open-market purchase	+5	$79.00	3,217	Form 4
20 August 2026	Reeve Graham D.	COO	Shares withheld for tax	−762	$78.00	28,554	Form 4
20 August 2026	Binstein Richard	EVP Gen'l Counsel & Secretary	Shares withheld for tax	−450	$78.00	24,417	Form 4
20 August 2026	Curtis Jason Travis	Interim CFO	Shares withheld for tax	−40	$78.00	3,853	Form 4
20 August 2026	Williams Eric Joseph	President and COO	Shares withheld for tax	−714	$78.00	39,617	Form 4
12 June 2026	Minan Peter Francis	Director	Open-market purchase	+1	$66.50	3,212	Form 4
9 June 2026	Minan Peter Francis	Director	Open-market purchase	+288	$61.50	3,211	Form 4
8 June 2026	Minan Peter Francis	Director	Open-market purchase	+492	$63.14	2,923	Form 4
20 May 2026	Reeve Graham D.	COO	Shares withheld for tax	−762	$62.24	29,316	Form 4
20 May 2026	Curtis Jason Travis	Interim CFO	Shares withheld for tax	−40	$62.24	3,893	Form 4
19 May 2026	Gilmartin Kathleen A	Director	Grant or award	+2,306	$61.61	27,092	Form 4
19 May 2026	Harris Bernard A Jr	Director	Grant or award	+2,306	$61.61	20,914	Form 4
19 May 2026	Minan Peter Francis	Director	Grant or award	+2,306	$61.61	2,431	Form 4
19 May 2026	Swanson Regg E.	Director	Grant or award	+2,306	$61.61	15,492	Form 4
19 May 2026	Motsenbocker Anne	Director	Grant or award	+2,306	$61.61	9,812	Form 4
11 March 2026	Reeve Graham D.	COO	Open-market sale	−662	$78.86	30,078	Form 4
9 March 2026	Reeve Graham D.	COO	Open-market sale	−1	$78.52	0	Form 4
9 March 2026	Hendrickson Carey P	Chief Financial Officer	Returned to the company	−10,000	—	27,808	Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the U S Physical Therapy page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.